![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 37, 35362-35372, September 12, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

¶ ||
From the
McGill University AIDS Centre, Lady Davis
Institute-Jewish General Hospital, Montréal, Québec H3T 1E2 and
the Departments of
Microbiology and Immunology
and ¶Experimental Medicine, McGill University,
Montréal, Québec H3A 2T5, Canada
Resistance to nucleoside analogue inhibitors of the reverse transcriptase of the HIV-1 often involves phosphorolytic excision of the incorporated chain terminator. Previous crystallographic and modeling studies suggested that this reaction could only occur when the enzyme resides in a pre-translocational stage. Here we studied mechanisms of polymerase translocation using novel site-specific footprinting techniques. Classical footprinting approaches, based on the detection of protected nucleic acid residues, are not sensitive enough to visualize subtle structural differences at single nucleotide resolution. Thus, we developed chemical footprinting techniques that give rise to hyperreactive cleavage on the template strand mediated through specific contacts with the enzyme. Two specific cuts served as markers that defined the position of the polymerase and RNase H domain, respectively. We show that the presence of the next correct dNTP, following the incorporated chain terminator, caused a shift in the position of the two cuts a single nucleotide further downstream. The footprints point to monotonic sliding motions and provide compelling evidence for the existence of an equilibrium between pre- and post-translocational stages. Our data show that enzyme translocation is reversible and uncoupled from nucleotide incorporation and the release of pyrophosphate. This translocational equilibrium ensures access to the pre-translocational stage after incorporation of the chain terminator. The efficiency of excision correlates with an increase in the population of complexes that exist in the pre-translocational stage, and we show that the latter configuration is preferred with an enzyme that contains mutations associated with resistance to nucleoside analogue inhibitors.
Received for publication, April 23, 2003 , and in revised form, June 18, 2003.
* This work was supported by grants from the Canadian Institutes of Health Research (to M. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| To whom correspondence should be addressed: McGill University AIDS Centre (226), Lady Davis Institute-Jewish General Hospital, 3755, Chemin Côte-Ste-Catherine, Montréal, Québec H3T 1E2, Canada. Tel.: 514-340-8222 (ext. 3299); Fax: 514-340-7502; E-mail: mgoette{at}ldi.jgh.mcgill.ca.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
N. K. Duggal, L. Goo, S. R. King, and A. Telesnitsky Effects of Identity Minimization on Moloney Murine Leukemia Virus Template Recognition and Frequent Tertiary Template-Directed Insertions during Nonhomologous Recombination J. Virol., November 15, 2007; 81(22): 12156 - 12168. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Deval, M. H. Powdrill, C. M. D'Abramo, L. Cellai, and M. Gotte Pyrophosphorolytic Excision of Nonobligate Chain Terminators by Hepatitis C Virus NS5B Polymerase Antimicrob. Agents Chemother., August 1, 2007; 51(8): 2920 - 2928. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Marchand, K. L. White, J. K. Ly, N. A. Margot, R. Wang, M. McDermott, M. D. Miller, and M. Gotte Effects of the Translocation Status of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on the Efficiency of Excision of Tenofovir Antimicrob. Agents Chemother., August 1, 2007; 51(8): 2911 - 2919. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Marchand, E. P. Tchesnokov, and M. Gotte The Pyrophosphate Analogue Foscarnet Traps the Pre-translocational State of HIV-1 Reverse Transcriptase in a Brownian Ratchet Model of Polymerase Translocation J. Biol. Chem., February 2, 2007; 282(5): 3337 - 3346. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jochmans, J. Deval, B. Kesteleyn, H. Van Marck, E. Bettens, I. De Baere, P. Dehertogh, T. Ivens, M. Van Ginderen, B. Van Schoubroeck, et al. Indolopyridones Inhibit Human Immunodeficiency Virus Reverse Transcriptase with a Novel Mechanism of Action J. Virol., December 15, 2006; 80(24): 12283 - 12292. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Tchesnokov, C. Gilbert, G. Boivin, and M. Gotte Role of Helix P of the Human Cytomegalovirus DNA Polymerase in Resistance and Hypersusceptibility to the Antiviral Drug Foscarnet J. Virol., February 1, 2006; 80(3): 1440 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sluis-Cremer, D. Arion, U. Parikh, D. Koontz, R. F. Schinazi, J. W. Mellors, and M. A. Parniak The 3'-Azido Group Is Not the Primary Determinant of 3'-Azido-3'-deoxythymidine (AZT) Responsible for the Excision Phenotype of AZT-resistant HIV-1 J. Biol. Chem., August 12, 2005; 280(32): 29047 - 29052. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Frankel, B. Marchand, D. Turner, M. Gotte, and M. A. Wainberg Impaired Rescue of Chain-Terminated DNA Synthesis Associated with the L74V Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2657 - 2664. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Meyer, A. J. Smith, S. E. Matsuura, and W. A. Scott Effects of Primer-Template Sequence on ATP-dependent Removal of Chain-terminating Nucleotide Analogues by HIV-1 Reverse Transcriptase J. Biol. Chem., October 29, 2004; 279(44): 45389 - 45398. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matamoros, S. Franco, B. M. Vazquez-Alvarez, A. Mas, M. A. Martinez, and L. Menendez-Arias Molecular Determinants of Multi-nucleoside Analogue Resistance in HIV-1 Reverse Transcriptases Containing a Dipeptide Insertion in the Fingers Subdomain: EFFECT OF MUTATIONS D67N AND T215Y ON REMOVAL OF THYMIDINE NUCLEOTIDE ANALOGUES FROM BLOCKED DNA PRIMERS J. Biol. Chem., June 4, 2004; 279(23): 24569 - 24577. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |